Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Seaport Therapeutics, Inc. (SPTX) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Seaport Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 2042347.
Total stock buying since 2026: $19,800,000.
Total stock sales since 2026: $0.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 1,100,000 | $19,800,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-05 | 1,100,000 | $19,800,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-05-04 | Gillis Steven | Buy | 1,100,000 | 18.00 | 19,800,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of SPTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Seaport Therapeutics, Inc. (symbol SPTX, CIK number 2042347) see the Securities and Exchange Commission (SEC) website.